Neumora Therapeutics (NMRA) PT Raised to $3 at Stifel
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on Neumora Therapeutics (NASDAQ: NMRA) to $3.00 (from $2.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
